Analyst Ratings for Rani Therapeutics (RANI)
RANI Rating Summary
RANI Price Target Summary
- Highest: $11.00 (H.C. Wainwright)
- Lowest: $5.00 (Canaccord)
- Average: $7.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.75 (+801.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$7.75 (+801.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | Chardan | Andreas Argyrides | New Coverage | Buy (N/A) |
6.00 (N/A) |
0.80 (0.86) |
7.5% | Details |
| 4/14/2026 | Lake Street | Daniel Brims | New Coverage | Buy (N/A) |
9.00 (N/A) |
0.78 (0.86) |
10.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
